CLINICAL_TRIALS
research
· 2026-01-14
Clinical Trial Update: OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma [NA]
Summary
The OMNI 3.1 Surgical System is being studied in adults with Primary open-angle glaucoma and is currently recruiting. Sponsor: Sight Sciences, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sight Sciences, Inc. | Conditions: Primary Open Angle Glaucoma | NA | Status: RECRUITING